Form 4: NeueHealth Director Andrew Slavitt Reports Transaction in Beneficial Ownership

Director Andrew Slavitt reports changes in beneficial ownership of NeueHealth, Inc. stock, including the vesting of restricted stock units and transactions by related entities.

Summary

• Andrew Slavitt, a director of NeueHealth, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On May 12, 2024, 4,755 shares of common stock were acquired, and 8,029 shares were disposed of.
• These transactions involved the vesting of 4,755 restricted stock units, each representing a contingent right to receive one share of NeueHealth's common stock.
• Slavitt also indirectly owns shares through Slavitt Holdings LLC (5,625 shares), Town Hall Ventures LP (52,969 shares), and Town Hall Ventures II LP (30,687 shares).
• An additional 10,500 restricted stock units were acquired on May 13, 2024, which will vest on May 13, 2025.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates